Meegdes M, Ibragimova KIE, Lobbezoo DJA, Vriens IJH, et al. The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry. Breast Cancer Res Treat 2022 Jan 13. pii: 10.1007/s10549-021-06472.
PMID: 35025003